| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/04/2026 | ±2.2% | +4.2% | under-priced |
| 10/30/2025 | ±2.0% | +7.7% | under-priced |
| 07/31/2025 | ±1.4% | +4.6% | under-priced |
| 05/01/2025 | ±2.3% | -1.4% | over-priced |
| 10/31/2024 | ±1.3% | +8.5% | under-priced |
| 08/01/2024 | ±2.2% | -8.3% | under-priced |
| 05/02/2024 | ±1.4% | -6.1% | under-priced |
| 10/31/2023 | ±1.4% | +0.5% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $1.77 | $2.0B | $407M |
| Q1 FY2026 | $1.74 | $1.9B | $399M |
| Q4 FY2025 | $1.73 | $2.0B | $399M |
| Q3 FY2025 | $1.60 | $1.9B | $371M |
Ametek, Inc. (AME) reports in 121 days, with the next report estimated for 01/11/2027. Across the last 8 reports, options priced an average ±1.8% earnings move while the stock actually moved 5.2% on average — the market has tended to under-price AME's earnings risk. Fundamentals into the print: EPS up 14.2% year-over-year, revenue up 15.0%. QuantLogix's live 5-factor engine currently reads AME as a buy at 56/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →